Skip to main content
SpringerLink
Log in

Nikkomycin Z

SP 920704

  • Section 2: Antifungal Agent
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Swezey RR, Hector RF, Khandwala A, et al. Pharmacokinetics and safety of nikkomycin Z after oral administration of single doses to normal volunteers. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1997 Sep 28–Oct 1; Toronto, 160

    Google Scholar 

  2. Clemons KV, Stevens DA. Efficacy of nikkomycin Z against experimental pulmonary blastomycosis. Antimicrob Agents Chemother 1997 Sep; 41: 2026–8

    PubMed  CAS  Google Scholar 

  3. Najvar LK, Bocanegra RA, Montalbo EM, et al. Nikkomycin Z in a murine histoplasmosis model. 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1997 Sep 28–Oct 1; Toronto, 160

    Google Scholar 

  4. Graybill JR, Najvar LK, Bocanegra R, et al. Efficacy of nikkomycin Z in the treatment of murine histoplasmosis. Antimicrob Agents Chemother 1998 Sep; 42: 2371–4

    PubMed  CAS  Google Scholar 

  5. Li RK, Fothergill AW, Rinaldi MG. In vitro antifungal activity of SP-920704 in combination with fluconazole and itraconazole. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1996 Sep 15–18; New Orleans, 132

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nikkomycin Z. Drugs R&D 1, 179–180 (1999). https://doi.org/10.2165/00126839-199901020-00017

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199901020-00017

Keywords

Search

Navigation